• Dr. Mohammad Azam
• Dr. B. D. Khan
• Dr. Mohammad Saad Ahmad Khan

Nonalcoholic fatty liver disease (NAFLD) is now considered as a hepatic feature of metabolic syndrome and is a clinical spectrum ranging from simple steatosis (Non Alcoholic Fatty Liver, NAFL) to Non Alcoholic Steatohepatitis (NASH) . The former has a benign prognosis but latter is associated with fibrosis and progression to liver cirrhosis and hepatocellular carcinoma (HCC). NAFLD is a rapidly growing disease in both developed and developing countries and is probably the most common cause of abnormal liver function tests worldwide. The prevalence of NAFLD appears to be increasing in parallel with the epidemics of obesity. Now it has become the most common cause of chronic liver disease after hepatis B, hepatitis C and alcohol. In Unani Medicine a number of herbal drugs, plants as a whole or their parts are extensively used for the cure of liver derangement, and are scientifically evaluated for their safety and efficacy. In the present study, a comparative therapeutic evaluation of Qurs-e-Zarishk and Ursodeoxycholic Acid (UDCA) in 60 patients of Nonalcoholic fatty liver was done. The study shows that the Unani Test Formulation ‘Qurs-e-Zarishk’ produces significant improvement in cases of Nonalcoholic fatty liver. Comparison of Qurs-e-Zarishk with the standard agent UDCA shows that in the most parameters, the later is more effective while in some parameters Qurs-e-Zarishk is more effective. Keywords: Unani Medicine, NAFLD, Ursodeoxycholic Acid (UDCA), NASH, Qurs-e-Zarishk.

Unani Medicine, NAFLD, Ursodeoxycholic Acid (UDCA), NASH, Qurs-e-Zarishk.

"A Comparative Clinical Study of Qurs-E-Zarishk and Ursodeoxycholic Acid in Non Alcoholic Fatty Liver Disease", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.4, Issue 9, page no.431-438, September-2017, Available :http://www.jetir.org/papers/JETIR1709068.pdf

"A Comparative Clinical Study of Qurs-E-Zarishk and Ursodeoxycholic Acid in Non Alcoholic Fatty Liver Disease", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.4, Issue 9, page no. pp431-438, September-2017, Available at : http://www.jetir.org/papers/JETIR1709068.pdf